This site is intended for health professionals only

At the heart of general practice since 1960

New type 2 diabetes drug launched

The second of a new class of oral hypoglycaemic drugs for type 2 diabetes has been launched in the UK.

Recently Pulse revealed that GPs were increasingly turning from rosiglitazone to other prescribing options.

Vildagliptin, which is available alone and in combination with metformin, had a neutral effect on weight gain in clinical trials.

Dr Eugene Hughes, GP, Isle of Wight and chair of Primary Care Diabetes Europe, said the new drug could be ‘a potential solution to a very real problem.'

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say